Advertisement

A monocentric therapy study: An approach to optimize the results of the treatment of osteosarcoma by protocols based upon HDMTX, associated with systematic conservative surgery

  • N. Delepine
  • G. Delepine
  • J. C. Desbois
Part of the Cancer Treatment and Research book series (CTAR, volume 62)

Abstract

In order to understand why Rosen’s protocol [1] has not been reproduced by most groups [2, 3, 4, 5] that used the same scheme, we started preliminary study in 1984 using T10 to analyze methotrexate (MTX) pharmacokinetics and its correlations with clinical and histological results. From 1985 to 1989 a second pilot study was conducted to optimize the results of Rosen while conducting a pharmacokinetic analysis to understand the reasons for failures in attempts to reproduce T10 and to emphasize the fundamental points for curing osteosarcomas.

Keywords

Preoperative Chemotherapy Poor Responder Good Responder Therapeutic Intensity Folinic Acid Rescue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rosen G, Marcove RC, Caparros B, et al. Primary osteogenic sarcoma. The rationale for preoperative chemotherapy and delayed surgery. Cancer 43:2163–2177, 1979.PubMedCrossRefGoogle Scholar
  2. 2.
    Solheim OP. Scandinavian Sarcoma Group: Adjuvant chemotherapy in patients with osteosarcoma preliminary results. In Fourth European Conference on Cancer Care, Madrid, 1987.Google Scholar
  3. 3.
    Brunat-Mentigny M, Demaille MC, Quitana E, et al. La reproduction en France du protocole de Rosen pour les ostéosarcomes. Bull Cancer 75:201–206, 1988.PubMedGoogle Scholar
  4. 4.
    Kalifa C, Mlika N, Dubousset J, et al. Expérience du protocole T10 dans le service de Pédiatrie de l’Institut Gustave Roussy. Bull Cancer 75:207–221, 1988.PubMedGoogle Scholar
  5. 5.
    Baranzelli MC, Gosselin P, Cazin JL, et al. Expérience du protocole T10 de Rosen au Centre Oscar Lambret (Lille) de 1982 à 1985, Ann Ped 35:253–259, 1988.Google Scholar
  6. 6.
    Rosen G, Capparos B, Huvos AG. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49:1221–1230, 1982.PubMedCrossRefGoogle Scholar
  7. 7.
    Delepine N, Delepine G, Trifaud A, et al. Evaluation of the optimal length of neoadjuvant chemotherapy in osteogenic sarcoma. In: Neoadjuvant Chemotherapy. Colloque INSERM, Eds. John Libbey Eurotext, 1986, 581–585.Google Scholar
  8. 8.
    Desbois JC, Delepine N, Delepine G. L’ostéosarcome ostéogénique, un modèle de maladie devenue curable grâce à l’approche multidisciplinaire de son traitement. CR Soc Biol 182:523–537, 1988.Google Scholar
  9. 9.
    Delepine N, Delepine G, Desbois JC, et al. Value of chemosensibility score to modulate histological grading after short neoadjuvant chemotherapy in high grade osteosarcoma. In: Second International Congress on Neoadjuvant Chemotherapy, Paris, 1988.Google Scholar
  10. 10.
    Delepine N, Desbois JC, Delepine G, et al. Individualisation de posologie du methotrexate HD par le dosage de conentration plasmatique. Intérêt thérapeutique dans le sarcome ostéogénique. Bull Cancer 76:913–918, 1989.PubMedGoogle Scholar
  11. 11.
    Winkler K, Beron G, Delling G, et al. Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COOS 82) with salvage chemotherapy based on histological tumor response. J Clin Oncol 6:329–337, 1988.PubMedGoogle Scholar
  12. 12.
    Bramwell V, Sneath a, Jelliffe A, et al. for EORTC Osteosarcoma Intergroup. Randomized study of chemotherapy in treatment of osteosarcoma. Proc ECCO 4, 1987, abstract 884.Google Scholar

Copyright information

© Springer Science+Business Media New York 1993

Authors and Affiliations

  • N. Delepine
    • 1
  • G. Delepine
  • J. C. Desbois
    • 2
  1. 1.Oncologic Pediatric ServiceUniversity Hospital Robert DebreParisFrance
  2. 2.Pre-Gentil ClinicRosnyFrance

Personalised recommendations